Blend Labs, Inc. filings document the company’s digital banking origination business, operating results, governance, capital actions, and material corporate events. Form 8-K reports cover quarterly and annual financial results, supplemental Regulation FD materials, product and service disclosures, officer-transition matters, and board-authorized repurchases of Class A common stock.
Blend’s proxy materials describe annual meeting matters, board elections, executive compensation, stockholder voting procedures, and related governance disclosures. Recent filings also document completed corporate actions, including the sale of substantially all assets and liabilities of Title365 Company, Blend’s former title insurance business.
Blend Labs, Inc. reported second quarter 2026 results with revenue of $33.8 million, up 7% year over year, driven by $31.4 million of software platform revenue and $2.4 million of professional services. GAAP gross margin was 74% and non‑GAAP gross margin improved to 78%. GAAP operating loss narrowed to $1.6 million, while non‑GAAP operating income increased to $7.0 million and non‑GAAP operating margin reached 21%. GAAP diluted net loss from continuing operations attributable to common stockholders was $0.03 per share, and non‑GAAP diluted net income per share was $0.00.
Management stated that revenue was near the high end of guidance and non‑GAAP operating income exceeded the high end. Blend repurchased 11.0 million shares for $18.2 million in the quarter, with $13.2 million remaining under its authorization, and generated free cash flow of $6.9 million. Cash and cash equivalents were $23.3 million and total assets were $143.6 million as of June 30, 2026. Autopilot became commercially available on July 1 with six lenders signed, and the company added or expanded 14 customer relationships in the quarter. For the third quarter of 2026, Blend guides to total revenue of $31–$33 million and non‑GAAP operating income of $3–$4 million.
Blend Labs, Inc. reported the results of its 2026 annual meeting of stockholders held on June 17, 2026. Stockholders elected seven directors, including Nima Ghamsari and Timothy J. Mayopoulos, with strong majorities of votes cast. Each director will serve until the next annual meeting and until a successor is elected and qualified.
Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as Blend Labs’ independent registered public accounting firm for the fiscal year ending December 31, 2026, with over 260 million votes cast in favor and very few abstentions.
Mayopoulos Timothy J reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs, Inc. reported that director Timothy J. Mayopoulos received a grant of 50,000 Restricted Stock Units (RSUs) on Class A Common Stock. Each RSU represents a contingent right to receive one share of BLND Class A Common Stock.
The RSUs will vest on the earlier of the one-year anniversary of the grant date or the day prior to Blend Labs’ next annual meeting of shareholders, as long as Mayopoulos continues as a service provider through the applicable vesting date. This is a compensation-related equity award rather than an open-market share purchase or sale.
Sullivan Bryan Edmund reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs director Bryan Edmund Sullivan received a grant of 50,000 Restricted Stock Units (RSUs). Each RSU represents a right to receive one share of Blend Labs Class A common stock. The RSUs vest after about one year or just before the company’s next annual shareholder meeting, if he continues as a service provider.
Lantz Erin N reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs, Inc. director Erin N. Lantz received a grant of 50,000 Restricted Stock Units, each representing a contingent right to receive one share of Blend Labs Class A Common Stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date or the day before the next annual meeting of shareholders, provided she continues as a service provider through the vesting date. Following this award, she is reported as holding 50,000 RSUs directly.
Chen Gerald C. reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs director Gerald C. Chen received a grant of 50,000 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Blend Labs Class A common stock. The RSUs will vest on the earlier of one year from the grant date or the day before the company’s next annual shareholder meeting, as long as Chen continues to serve as a service provider through that vesting date.
Woersching Eric H. reported acquisition or exercise transactions in this Form 4 filing.
Blend Labs, Inc. director Eric H. Woersching received a grant of 50,000 Restricted Stock Units on June 17, 2026. Each RSU represents a contingent right to receive one share of Blend Labs Class A common stock, bringing his reported RSU holdings to 50,000 units.
The RSUs will vest on the earlier of the one-year anniversary of the grant date or the day before the company’s next annual meeting of shareholders, as long as he continues to serve as a Service Provider through the vesting date.
Blend Labs, Inc. insider entities associated with Haveli Investments reported significant open-market purchases of Class A Common Stock. Across June 11–15, 2026, Haveli Brooks Aggregator, L.P. bought a total of 1,156,928 shares at weighted average prices around $1.70 per share, increasing its indirect holdings to 18,693,657 shares. A separate line reflects 130,000 shares held indirectly through a family trust for the spouse of Brian N. Sheth. The filing notes that actual trade prices on each day fell within specified ranges around the reported weighted averages.
Blend Labs, Inc. director Eric H. Woersching exercised restricted stock units to acquire 50,000 shares of Class A Common Stock on June 11, 2026. These RSUs represented a contingent right to receive one share of Class A stock per unit. After the transaction, he directly holds 80,000 Class A shares and no remaining RSUs from this grant. The RSUs vested after the earlier of one year from grant or just before the next annual shareholder meeting, contingent on his continued service.